Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 196 AL 210

Motoric Cognitive Risk Syndrome as a Predementia Marker: Insights From a Bibliometric and Visual Analysis

Zhao B, Yang Z, Shen Y, Zhu J, Cao M, Yu Q, Hou X, Zou Z.

Eur J Neurosci. 2026 Oct;64(8):e70723. doi: 10.1111/ejn.70723.

The Interplay Between Oophorectomy and Alzheimer's Disease: A Narrative Review

Xu S, Fu X, Zuo L, Wang M.

Medicina (Kaunas). 2026 Oct 21;62(10):2043. doi: 10.3390/medicina62102043.

Impact of GLP-1 Receptor Agonists on Cognitive Performance in Adults at Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Abbatecola AM, Migliara G, D'Agostino F, Veronese N, Giuliani A, Caponnetto S, Corbi G, Signoriello E, Incalzi RA, Paolisso G.

Nutrients. 2026 Oct 9;18(20):3312. doi: 10.3390/nu18203312.

Electroconvulsive Therapy and the Long-Term Risk of Dementia: Conceptual Issues, Methodological Issues, and Recent Findings

Andrade C.

J Clin Psychiatry. 2026 Oct 26;87(4):26f16711. doi: 10.4088/JCP.26f16711.

From latency to neurodegeneration: varicella-zoster virus reactivation and dementia risk, with a focus on herpes zoster ophthalmicus

Samalia PD, Wang R, Brickell K, Netzler N, Meyer J, Niederer RL.

J Neurovirol. 2026 Oct 29;32(6):50. doi: 10.1007/s13365-026-01351-5.

Clinical and biological relevance of objectively-defined subtle cognitive decline in Alzheimer's disease: a narrative review of neuroimaging, biomarker, and clinical progression studies

Gonzalez AI, Martinez JE, Giudicessi A, Rowe M, Ku V, Tristão-Pereira C, He B, Malotaux V, Quiroz YT.

J Prev Alzheimers Dis. 2026 Oct;13(8):100604. doi: 10.1016/j.tjpad.2026.100604. Epub 2026 May 19.

Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment

Kuhn E, Kleineidam L, Stark M, Peters O, Hellmann-Regen J, Preis L, Gref D, Priller J, Spruth EJ, Gemenetzi M, Schneider A, Fliessbach K, Wiltfang J, Bartels C, Hansen N, Rostamzadeh A, Düzel E, Glanz W, Incesoy E, Buerger K, Janowitz D, Stöcklein S, Perneczky R, Rauchmann BS, Teipel SJ, Kilimann I, Laske C, Sodenkamp S, Spottke A, Kronmüller M, Roeske S, Brosseron F, Ramirez A, Synofzik M, Schmid MC, Jessen F, Wagner M; Alzheimer’s Disease Neuroimaging Initiative; DELCODE study group.

J Prev Alzheimers Dis. 2026 Oct;13(8):100609. doi: 10.1016/j.tjpad.2026.100609. Epub 2026 May 29.

Blood-based biomarkers and the current landscape of Alzheimer's disease diagnosis: ethical considerations and practical guidance

Naini SM, Mantyh WG, Waldron EJ, Satin DJ, Basso MR, Garland M, McManimen S, Whiteside DM.

J Clin Exp Neuropsychol. 2026 Oct;48(8):769-781. doi: 10.1080/13803395.2026.2681010. Epub 2026 May 30.

Combating Alzheimer's through sleep and exercise (CASE): A study protocol

Chung D, Larsen BA, Garchitorena Gomez LG, Ramos AR, Kirk-Sanchez NJ, Jean-Louis G, Seixas AA.

Geroscience. 2026 Oct;48(5):6353-6374. doi: 10.1007/s11357-026-02337-1. Epub 2026 Jun 6.

A Multimodal Explainable AI Framework for Early Detection of Alzheimer's Disease Using MRI, PET, and Clinical Assessments

Kirthiga N, Suresh Kumar N.

Semin Ultrasound CT MR. 2026 Oct;47(5):314-325. doi: 10.1053/j.sult.2026.06.009. Epub 2026 Jun 9.

The time interval from amyloid to tau PET positivity varies by age, sex and APOE-ε4 status

Milà-Alomà M, Hausle I, Petersen KK, Thropp P, Schindler SE, Tosun D; Alzheimer’s Disease Neuroimaging Initiative.

J Prev Alzheimers Dis. 2026 Oct;13(8):100622. doi: 10.1016/j.tjpad.2026.100622. Epub 2026 Jun 17.

Diagnostic accuracy of CSF and plasma pTau-181, pTau-217, and pTau-231 for Alzheimer's disease: a diagnostic meta-analysis

Mohammed HE, Haseeb ME, Nasser M, Hanen G, Abdelkader MS, Yaser H, Yaser S, Samir A, Arafeh Y, Wagdy M, Darwish MK.

Acta Neurol Belg. 2026 Oct;126(5):1649-1670. doi: 10.1007/s13760-026-03107-8. Epub 2026 Jun 26.

Predicting cognitive function in Alzheimer's clinical trials via amyloid β-protein biomarkers

Sui Z, Feng A, Gong Y, Zha S, Lv Y, Zheng Q, Li L, Wang Y.

Br J Clin Pharmacol. 2026 Oct;92(10):3576-3585. doi: 10.1002/bcp.70665. Epub 2026 Jun 28.

Gingipains as macromolecular mediators at the periodontal-brain interface: Mechanistic, diagnostic, and therapeutic evidence in Alzheimer's and Parkinson's diseases

Dhar I, Gupta S, Mishra R, Dadhich A.

Int J Biol Macromol. 2026 Oct;377:153320. doi: 10.1016/j.ijbiomac.2026.153320. Epub 2026 Jul 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias